D-0023-2026 Class III Ongoing
FDA drug recall D-0023-2026 was initiated by STAQ Pharma, Inc. on Oct 9, 2025 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 22, 2025
- Initiation Date
- Oct 9, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Distribution pattern
Nationwide in the U.S.
Code information
Lot #: 25104595A, Expiry: 27DEC2025.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0023-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026